African Journal of Paediatric Surgery About APSON | PAPSA  
Home About us Editorial Board Current issue Search Archives Ahead Of Print Subscribe Instructions Submission Contact Login 
Users Online: 887Print this page  Email this page Bookmark this page Small font size Default font size Increase font size 
 
 
ORIGINAL ARTICLE
Ahead of Print

Use of propanolol versus intralesional bleomycin in the management of infantile hemangioma


1 Shaheed Zulfiqar Ali Bhutto Medical University, PIMS Hospital, Islamabad, Pakistan
2 Rawalpindi Medical University, Holy Family Hospital, Rawalpindi, Pakistan
3 Shifa International Hospital, Islamabad, Pakistan

Correspondence Address:
Ali Raza Chaudhry,
Department of Paediatric Surgery, City Care Hospital, Kalli Tanki, Rawalpindi
Pakistan
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ajps.ajps_55_22

Introduction: Infantile haemangiomas (IHs) are widespread vascular tumours having incidence of 10% and most of them involute spontaneously. However, they are known to be located in proximity of vital organs and can have poor cosmetic and functional sequel if left untreated. Objective: To assess the efficacy of oral propranolol and intraleisonal bleomycin in the treatment of infantile cutaneous haemangioma in terms of size regression. Materials and Methods: IH patients presenting in the outpatient department in PIMS were divided randomly by stratified random sampling in two groups. Out of 90 patients, 45 patients had treatment with oral propranolol and other 45 patients received intralesional bleomycin. Baseline size of haemangiomas was taken and regression in size was noted again at 3 and 6 months. Mean and standard deviation were calculated for the age and size of haemangioma in both groups. The mean size regression for both treatments was compared using independent t-test taking P < 0.05 as significant. Results: Out of 90 cases included in this study, the mean age of patients was 10.9 ± 6.1 months in Bleomycin group compared to 10.2 ± 6.9 months in propranolol group. The average size of haemangioma at baseline was 9.5 cm2 in bleomycin group compared to 8.9 cm2 in propranolol group. At 3 months after the intervention, the mean size regression was 3.5 cm2 in bleomycin group compared to 5.3 cm2 in propranolol group and after 6 months of treatment with bleomycin group the mean size of haemangioma was 0.45 cm2, whereas in the propranolol group, it was 2.8 cm2 and difference in the two was found statistically highly significant (P < 0.001). Conclusion: The present study concluded that treatment with intralesional injection Bleomycin for IHs helps in size reduction more efficiently with minimal side effects as compared to oral propranolol for comparable sized haemangiomas.


[Full text not available ] [PDF]
Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Chaudhry AR
    -  Gondal MF
    -  Khan R
    -  Rehman IU
    -  Saman R
    -  Abbas K
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed35    
    PDF Downloaded4    

Recommend this journal